Minovia Therapeutics
Noa Sher is currently the Chief Scientist at Minovia Therapeutics. Prior to this, Noa held roles such as Product Profile Research Manager at Pluristem Therapeutics and Head of the Bioinformatics Service Unit at the University of Haifa. Noa also served as the CTO of a startup at Technion and Chief Biologist at Tauber Bioinformatic Research Center. With a background in biochemistry and endocrinology, Noa has extensive experience in bioinformatics, molecular biology, and research in various organizations and institutions.
Previous companies
This person is not in any offices
Minovia Therapeutics
Minovia Therapeutics is a clinical-stage international biotechnology company, established in hopes to bring life changing therapies to patients with Mitochondrial diseases, as fast as responsible. Following compassionate use cases performed in Sheba Medical hospital in Israel, using our proprietary Mitochondrial Augmentation Therapy, Minovia is now conducting the first of its kind clinical trial for Pearson syndrome, an ultra-rare pediatric disease.